Racial and ethnic disparities in clinical trials for pediatric obesity
With the exception of Black and Hispanic children, historically marginalized racial groups were underrepresented in pediatric obesity trials, signifying a need to improve diversity of participants in these trials. Additionally, there are substantial gaps in the documentation of race and ethnicity information. Concerted efforts are needed to ensure adequate reporting of race and ethnicity information in clinical trials.
Authors
- Fatima Cody Stanford (ORCID: https://orcid.org/0000-0003-4616-533X)
- Mei‐Sing Ong (ORCID: https://orcid.org/0000-0002-1241-1013)
- Catherine G. Coughlin (ORCID: https://orcid.org/0000-0003-2441-3363)
- Emilie S. Zoltick (ORCID: https://orcid.org/0000-0002-7965-9769)
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- Obesity
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1002/oby.24228
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for the National Institutes of Health
- Amgen
- Eli Lilly and Company
- Novo Nordisk
- National Institutes of Health
- Agency for Healthcare Research and Quality
- National Institute on Minority Health and Health Disparities